Surgalign Holdings, Inc. provided revenue guidance for the year 2022. The company estimates it will report full year 2022 revenue of approximately $82.0 million.
Surgalign Holdings, Inc.
Equities
SRGA
US86882C2044
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-1.88% | 3.04TCr | |
+38.15% | 882.04Cr | |
+42.57% | 458.79Cr | |
-29.79% | 263.98Cr | |
-9.44% | 158.67Cr | |
-22.85% | 134.97Cr | |
-37.12% | 107.61Cr | |
+10.08% | 92Cr | |
-42.90% | 80Cr |